HEC CJ Pharma (1558.HK)'s Merger Deal with Sunshine Lake Pharma - Almost No Investment Value

337 Views16 May 2024 08:55
​Sunshine Lake Pharma plans to privatize and merge with CJ Pharma.However, with an outdated pipeline, the new entity's valuation performance will be disappointing, and thus has little investment value
What is covered in the Full Insight:
  • Merger Announcement
  • Rationale Behind the Deal
  • CJ Pharma's Performance and Sunshine Lake Pharma's Valuation
  • Analysis of Sunshine Lake Pharma’s Pipeline
  • Comparative Market Value Post-Merger
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
x